🇺🇸 FDA
Pipeline program

Placebo to match LY, Retatrutide, Retatrutide, Retatrutide, Retatrutide, Retatrutide

J1I-MC-GZQD

Phase 3 small_molecule active

Quick answer

Placebo to match LY, Retatrutide, Retatrutide, Retatrutide, Retatrutide, Retatrutide for Overweight, Chronic Low Back Pain (CLBP), Obesity is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly Co.
Indication
Overweight, Chronic Low Back Pain (CLBP), Obesity
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials